Description
Speaker:
Diane Ashiru-Oredope MPharm DipClinPharm MPH PhD PFPH FRPharmS FFRPS (consultant)
- Lead Pharmacist & Joint Head, AMR PROGRESS Section, UK Health Security Agency
- Honorary Chair & Professor of Pharmaceutical Public Health, University of Nottingham and University of Bristol;
- Honorary Lecturer, University College London
- Chair, Executive Committee of the ESCMID Study Group for Antimicrobial Stewardship
- Chair, English Surveillance Programme for Antimicrobial Utilisation & Resistance (ESPAUR)
- Deputy Chief Scientist, Royal Pharmaceutical Society (August 2023-December 2025)
- National Lead World AMR Awareness Week and European Antibiotic Awareness Day (EAAD) and Antibiotic Guardian campaign
Learning objectives
By the end of the webinar, participants should be able to:
- Explain the role of clinical pharmacists in developing and/or implementing AMS interventions in resource-limited and diverse health settings
- Critically consider how AMS interventions need to be adapted for feasibility, equity, and sustainability
- Design a pragmatic pharmacist-led AMS approach relevant to their own context
Description
The aim of the webinar is to support clinical pharmacists translate AMS principles into feasible, context-appropriate interventions in resource-limited and diverse health systems.
Diane Ashiru-Oredope, a Credentialed Consultant Pharmacist is Lead Pharmacist for Antimicrobial Resistance and Healthcare Associated Infections, UK Health Security Agency. She is Honorary Chair & Professor of Pharmaceutical Public Health at University of Nottingham. An antimicrobial pharmacist by background, Diane has led or significantly contributed to projects that have shaped national and international policy in tackling antimicrobial resistance, including UK AMR national action plan, WHO policy guidance on integrated antimicrobial stewardship activities and the global Antibiotic Guardian campaign. From 2016 until March 2022, she was advisor and Global AMR lead for the Commonwealth Pharmacists Association and between August 2023 and December 2025 she was Deputy Chief Scientist for Royal Pharmaceutical Society. She is research active and contributes proactively within academia including successfully leading or significantly contributing to more than 120 peer-review publications. She is on the editorial board of BMC Public Health Journal and was previously an Editor of the Journal of Antimicrobial Chemotherapy Journal. She was awarded a 4-year NIHR Senior Clinical and Practitioner Research Award in 2024.
